Skip to main content
Top

2024 | OriginalPaper | Hoofdstuk

39. The menopause, the perimenopause and the postmenopause

Auteurs : Drs. Dorenda K. E. van Dijken, Dr. Maryam Kavousi, Drs. Monique M. A. Brood-van Zanten, Dr. Annegreet G. Vlug, Dr. Mick A. A. van Trotsenburg, Prof.dr. Birit F. P. Broekman

Gepubliceerd in: Textbook of Obstetrics and Gynaecology

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Summary

Menopause is a transition phase. Four out of five women experience some kind of discomfort and one third of these women experience serious complaints. Vasomotor symptoms are the most common complaints, but menstrual disorders, mood swings, joint problems, urovaginal symptoms, mental health problems, sleeping and sexual disorders may also occur. For these women the menopause has a serious impact on quality of life and consecutively societal consequences. Several treatment options are available. To date, there is overwhelming scientific evidence that the benefits outweigh the risks of menopausal hormonal therapy (MHT). In the past, following the WHI study risks have been overrated or incorrectly interpreted. It is of importance that prescribing MHT should be individualised, based on the type of complaints, individual preferences and risks. Non-hormonal alternatives are available. For all women after menopause, healthy ageing and prevention of chronic diseases is of the essence. Thus a life course approach is important to be able to proactively take preventive measures for chronic diseases with high morbidity and mortality risk, such as gender specific cardiovascular diseases, mental health disorders and osteoporosis.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Woordenlijst
Anti-Müllerian hormone
A glycoprotein hormone structurally related to inhibin and activin from the transforming growth factor beta superfamily, whose key roles are in growth differentiation and folliculogenesis.
Body mass index
A key index for relating weight to height.
Bone mineral density
A measure of bone density, reflecting the strength of bones as represented by calcium content.
Depression
A state of low mood and aversion to activity that can affect a person’s thoughts, behaviour, feelings, and sense of wellbeing.
Endometrial hyperplasia
A condition of excessive proliferation of the cells of the endometrium, or inner lining of the uterus.
Follicle stimulating hormone
A hormone, secreted by the anterior pituitary gland, which stimulates the development of ovarian follicles in the female and testicular function in the male.
Life course approach
An approach developed for analysing people’s lives within their structural, social and cultural contexts.
Luteinising hormone
A gonadotropin (a hormone that affects the function of the sex organs) that is released by the pituitary gland in response to luteinising hormone-releasing hormone.
Menopause
The absence of menstrual periods for 12 consecutive months.
Menopause transition
The transition from the reproductive age through to menopause.
Osteoporosis
Thinning of the bones, with reduction in bone mass, due to depletion of calcium and bone protein.
Premature ovarian insufficiency
A condition characterised by amenorrhoea, hypoestrogenism, and elevated serum gonadotropin levels in women younger than 40 years.
Vasomotor symptoms
Episodes of profuse heat accompanied by sweating and flushing.
Literatuur
1.
go back to reference Hale GE, Zhao X, Hughes CL, et al. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive ageing workshop (STRAW) staging system. J Clin Endocrinol Metab. 2007;92:3060–7.CrossRefPubMed Hale GE, Zhao X, Hughes CL, et al. Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive ageing workshop (STRAW) staging system. J Clin Endocrinol Metab. 2007;92:3060–7.CrossRefPubMed
2.
go back to reference Jaspers L. Health and ageing in older adults: a gender-specific and life course perspective. Thesis, 2017. Jaspers L. Health and ageing in older adults: a gender-specific and life course perspective. Thesis, 2017.
11.
go back to reference Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58(6):529–34.CrossRefPubMed Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58(6):529–34.CrossRefPubMed
12.
go back to reference De Villiers VT, et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013;16(3):316–37.PubMed De Villiers VT, et al. Global consensus statement on menopausal hormone therapy. Climacteric. 2013;16(3):316–37.PubMed
14.
go back to reference Genazzane R. et al. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper. Int J Gynecol Obstet. 2023;00:1–15. Genazzane R. et al. Counseling in menopausal women: How to address the benefits and risks of menopause hormone therapy. A FIGO position paper. Int J Gynecol Obstet. 2023;00:1–15.
Metagegevens
Titel
The menopause, the perimenopause and the postmenopause
Auteurs
Drs. Dorenda K. E. van Dijken
Dr. Maryam Kavousi
Drs. Monique M. A. Brood-van Zanten
Dr. Annegreet G. Vlug
Dr. Mick A. A. van Trotsenburg
Prof.dr. Birit F. P. Broekman
Copyright
2024
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2994-6_39